MedPath

To evaluate efficacy and safety of Isoxsuprine Hydrochloride in females with preterm labor.

Phase 4
Completed
Conditions
Health Condition 1: null- Preterm labor
Registration Number
CTRI/2018/04/013262
Lead Sponsor
Dr PB Jaju
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1.Gestational age 24-37 weeks

2.Regular uterine contractions, 2 or more than 2 per 20 minutes each lasting for at least 20 seconds

3.Cervical dilatation less than 3 cm

4.Cervical effacement less than 50%.

5.Intact membrane

Exclusion Criteria

1.Antepartum hemorrhage

2.Fetal malformations

3.Pregnancy with heart disease and diabetes mellitus

4.Multiple pregnancies

5.Hydramnios

6.Prolonged PROM

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath